← Back to All Filings

Vanguard Reports 0% Stake in ResMed Due to Internal Realignment

Low SignificanceMarch 27, 2026 at 11:35:25 AM EDT

RESMED INC

$RMDSCHEDULE 13G/ACIK: 0000943819

Subscribe to track RMD

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Vanguard Reports 0% Stake in ResMed Due to Internal Realignment

Company: ResMed Inc Form: SCHEDULE 13G/A | Filed: 2026/03/27 Significance: Low (Administrative)

Investor: The Vanguard Group Type: Institutional Advisor

Ownership Details: • Shares Reported: 0 • Ownership: 0% • Previous Status: Major Holder

Key Insight: The Vanguard Group reports 0 shares due to an internal realignment. Subsidiaries will now report beneficial ownership separately. This is a change in reporting structure, not necessarily a liquidation of the underlying assets.

Market Context: ResMed Inc has a market cap of $32.92B. This filing represents a technical shift in how Vanguard reports holdings under SEC Release No. 34-39538.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: ResMed Inc

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Vanguard Group reports 0% ownership due to an administrative realignment where subsidiaries now report separately; this does not indicate a market sell-off.
  • Market Impact: Neutral - The filing is technical in nature.

Company Information

FieldValue
CompanyResMed Inc
CIK0000943819
IndustrySurgical & Medical Instruments
Market Cap$32.92 Billion

Insider/Investor Information

FieldValue
NameThe Vanguard Group
CIK0000102909
TypeInstitutional Advisor
LocationMalvern, PA

Transaction Details

FieldValue
Form TypeSCHEDULE 13G/A
Filing Date2026/03/27
Shares Reported0
Ownership %0%
Voting Power0

Financial Impact Assessment

Transaction Materiality

MetricValue
Reported Holding Value$0
% of Market Cap0%
Shares Outstanding145,680,000
Materiality AssessmentLow (Technical)

Impact Evaluation

  • Ownership Concentration: The filing indicates The Vanguard Group (parent) no longer holds reportable shares directly. However, the economic interest likely remains distributed among its subsidiaries/funds.
  • Transaction Significance: While a 0% report from a major holder typically signals a massive exit, the footnotes clarify this is a "realignment" in accordance with SEC Release No. 34-39538.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The reduction in ownership is due to a change in legal reporting structure (
Topics:#SECFiling#ResMed#Vanguard#InstitutionalOwnership#Schedule13G#MarketAnalysis#Investing#FinancialEducation

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.